SCHEMBL4674306

SCHEMBL4674306

O=c1[nH]c2ccc(C(O)CCN3CCC(Cc4ccc(F)cc4)CC3)cc2o1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 12/20 0.68
GRIN1 Q05586 8/20 0.68
GRIN2D O15399 5/20 0.68
GRIN3B O60391 5/20 0.68
GRIN2A Q12879 5/20 0.68
GRIN2C Q14957 5/20 0.68
GRIN3A Q8TCU5 5/20 0.68
MEN1 O00255 1/20 0.48
LMNA P02545 1/20 0.48
MAPT P10636 1/20 0.48
KMT2A Q03164 1/20 0.48
GMNN O75496 1/20 0.48
TP53 P04637 1/20 0.48
CYP3A4 P08684 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
NFKB1 P19838 1/20 0.48
THPO P40225 1/20 0.48
MTOR P42345 1/20 0.48
BLM P54132 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8545088 0.90 GRIN1 (0.64) GRIN2BGRIN1GRIN2DGRIN3BGRIN2A
SCHEMBL8544509 0.84 GRIN2B (0.67) GRIN2BGRIN1GRIN2DGRIN3BGRIN2A
SCHEMBL8109942 0.84 GRIN1 (0.74) GRIN2BGRIN1GRIN2DGRIN3BGRIN2A
SCHEMBL4675791 0.82 GRIN1 (0.71) GRIN2BGRIN1GRIN2DGRIN3BGRIN2A
SCHEMBL1908150 0.81 GRIN2B (1.00) GRIN2BGRIN1GRIN2DGRIN3BGRIN2A
SCHEMBL6163233 0.81 GRIN2B (0.69) GRIN2BGRIN1GRIN2DGRIN3BGRIN2A
SCHEMBL3445998 0.79 GRIN2D (0.73) GRIN2BGRIN1GRIN2DGRIN3BGRIN2A
Besonprodil SCHEMBL2257896 0.79 GRIN1 (0.66) GRIN2BGRIN1GRIN2DGRIN3BGRIN2A
Besonprodil SCHEMBL29388542 0.79 GRIN1 (0.66) GRIN2BGRIN1GRIN2DGRIN3BGRIN2A
SCHEMBL4674624 0.78 GRIN1 (0.62) GRIN2BGRIN1GRIN2DGRIN3BGRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002030422-A1 USE OF DEFINED SUBSTANCES THAT BIND TO THE SIGMA RECEPTOR FOR COMBATING SARCOMA AND CARCINOMA MERCK PATENT GMBH (DE) 2002-04-18 WO claimed
EP-1068202-B1 1-(3-HETEROARYLPROPYL- OR -PROP-2-ENYL)-4-BENZYLPIPERIDINES USED AS NMDA RECEPTOR ANTAGONISTS MERCK PATENT GMBH (DE) 2008-12-03 EP disclosed
US-6548516-B1 (NMDA=N-methyl-D-aspartate); where the heteroaryl is 3H-benzoxazol-2-one, 3H-benzothiazol-2-one, 3H-benzimidazol-2-one or indolin-2-one; excitatory amino acid antagonists for combating neurodegenerative disorders MERCK PATENT GMBH (DE) 2003-04-15 US disclosed
WO-2002030422-A1 USE OF DEFINED SUBSTANCES THAT BIND TO THE SIGMA RECEPTOR FOR COMBATING SARCOMA AND CARCINOMA MERCK PATENT GMBH (DE) 2002-04-18 WO disclosed
WO-2002030422-A1 USE OF DEFINED SUBSTANCES THAT BIND TO THE SIGMA RECEPTOR FOR COMBATING SARCOMA AND CARCINOMA MERCK PATENT GMBH (DE) 2002-04-18 WO disclosed
EP-1068202-A1 1-(3-HETEROARYLPROPYL- OR -PROP-2-ENYL)-4-BENZYLPIPERIDINES USED AS NMDA RECEPTOR ANTAGONISTS MERCK PATENT GmbH (DE) 2001-01-17 EP disclosed
WO-1999048891-A1 1-(3-HETEROARYLPROPYL- OR -PROP-2-ENYL)-4-BENZYLPIPERIDINES USED AS NMDA RECEPTOR ANTAGONISTS MERCK PATENT GMBH (DE) 1999-09-30 WO disclosed